Liquidia Corp (NAS:LQDA)
$ 11.57 -0.23 (-1.95%) Market Cap: 979.25 Mil Enterprise Value: 797.03 Mil PE Ratio: 0 PB Ratio: 8.85 GF Score: 60/100

Liquidia Corp at Bank of America Global Healthcare Conference Transcript

May 09, 2023 / 04:35PM GMT
Release Date Price: $7.6
Gregory Allen Harrison
BofA Securities, Research Division - Analyst

Hello, everyone. Welcome to day 1 of the Bank of America Healthcare Conference. I'm Greg Harrison, one of the Biotech Analysts here at Bank of America. And today, we have Liquidia Corporation, represented by Michael Kaseta, Chief Financial Officer. Thanks for joining us.

Michael Kaseta
Liquidia Corporation - CFO

Thanks for having me, Greg.

Gregory Allen Harrison
BofA Securities, Research Division - Analyst

Do you want to start off with maybe a quick opening remarks and then we'll jump into Q&A.

Michael Kaseta
Liquidia Corporation - CFO

Yes, that would be great. I mean, first of all, I just want to thank you for having us. It's really a great time for Liquidia. We think we're nearing the completion of our patent litigation with our competitor.

We are laser-focused on commercial readiness for launching YUTREPIA by the first half of 2024, if not earlier. And we're really excited to treat

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot